BACKGROUND: Angiopoietin-like proteins (ANGPTLs) 3 and 4 are circulating factors that participate in the regulation of lipid and glucose metabolism. SUBJECTS AND METHODS: We measured serum ANGPTL3 and 4 levels in 23 patients with obesity, 40 patients with obesity and type 2 diabetes mellitus (T2DM), 22 patients with anorexia nervosa (AN), 15 subjects undergoing 72-h fasting, and 12 patients with short bowel syndrome (SBS), and their changes after very-low-calorie diet (VLCD), bariatric surgery, partial realimentation, acute fasting, and parenteral nutrition in order to assess their possible role in metabolic regulations. RESULTS: Serum ANGPTL4 levels were higher in obese subjects without/with T2DM (94.50 ± 9.51 and 134.19 ± 7.69 vs. 50.34 ± 4.22 ng/ml, p < 0.001) and lower in subjects with AN relative to healthy control subjects (38.22 ± 4.48 vs. 65.80 ± 7.98 ng/ml, p = 0.002), while serum ANGPTL3 levels demonstrated inverse tendency. Nutritional status had no effect on ANGPTL3 and 4 mRNA expression in adipose tissue. Fasting decreased ANGPTL3 and increased ANGPTL4 levels, while VLCD reduced only ANGPTL3. Bariatric surgery and realimentation of AN or SBS patients had no effect on either ANGPTL. Multiple regression analysis identified BMI as an independent predictor of ANGPTL3; and BMI and HbA1c as independent predictors of ANGPTL4, respectively. CONCLUSIONS: Taken together, our data suggest that serum ANGPTL3 and 4 levels are influenced by nutritional status and fasting and could be involved in the metabolic disturbances present in obesity and AN.

3rd Department of Medicine Department of Endocrinology and Metabolism 1st Faculty of Medicine and General University Hospital Charles University Prague Prague Czech Republic

Centre for Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine and General University Hospital Charles University Prague Prague Czech Republic

Department of Psychiatry 1st Faculty of Medicine and General University Hospital Charles University Prague Prague Czech Republic

Department of Sports Medicine 1st Faculty of Medicine and General University Hospital Charles University Prague Prague Czech Republic

Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013;328:18–26. doi: 10.1016/j.canlet.2012.08.018. PubMed DOI

George J. Angiopoietin-like proteins: another player in the metabolic field. J. Hepatol. 2006;44:832–834. doi: 10.1016/j.jhep.2006.01.010. PubMed DOI

Oike Y, Yasunaga K, Suda T. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int. J. Hematol. 2004;80:21–28. doi: 10.1532/IJH97.04034. PubMed DOI

Xu L, et al. Angiopoietin-like 4: a double-edged sword in Atherosclerosis and ischemic stroke? Exp. Neurol. 2015;272:61–66. doi: 10.1016/j.expneurol.2015.05.020. PubMed DOI PMC

Zhang CC, et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 2006;12:240–245. doi: 10.1038/nm1342. PubMed DOI PMC

Schumacher A, et al. Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy. J. Hematol. Oncol. 2015;8:64. doi: 10.1186/s13045-015-0152-2. PubMed DOI PMC

Nakayama T, et al. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion. Oncol. Rep. 2010;24:599–606. doi: 10.3892/or_00000897. PubMed DOI

Sun Y, Long J, Zhou Y. Angiopoietin-like 4 promotes melanoma cell invasion and survival through aldolase A. Oncol. Lett. 2014;8:211–217. doi: 10.3892/ol.2014.2071. PubMed DOI PMC

Mattijssen F, Kersten S. Regulation of triglyceride metabolism by Angiopoietin-like proteins. Biochim. Biophys. Acta. 2012;1821:782–789. doi: 10.1016/j.bbalip.2011.10.010. PubMed DOI

Sukonina V, Lookene A, Olivecrona T, Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl Acad. Sci. USA. 2006;103:17450–17455. doi: 10.1073/pnas.0604026103. PubMed DOI PMC

Ge H, et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J. Lipid Res. 2005;46:1484–1490. doi: 10.1194/jlr.M500005-JLR200. PubMed DOI

Mehta N, et al. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler. Thromb. Vasc. Biol. 2014;34:1057–1063. doi: 10.1161/ATVBAHA.113.302802. PubMed DOI PMC

Koster A, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology. 2005;146:4943–4950. doi: 10.1210/en.2005-0476. PubMed DOI

Shan L, et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J. Biol. Chem. 2009;284:1419–1424. doi: 10.1074/jbc.M808477200. PubMed DOI PMC

Kaplan R, et al. Regulation of the angiopoietin-like protein 3 gene by LXR. J. Lipid Res. 2003;44:136–143. doi: 10.1194/jlr.M200367-JLR200. PubMed DOI

Steffensen KR, Gustafsson JA. Putative metabolic effects of the liver X receptor (LXR) Diabetes. 2004;53:S36–S42. doi: 10.2337/diabetes.53.2007.S36. PubMed DOI

Dijk W, Kersten S. Regulation of lipoprotein lipase by Angptl4. Trends Endocrinol. Metab. 2014;25:146–155. doi: 10.1016/j.tem.2013.12.005. PubMed DOI

Kavalkova P, et al. Preadipocyte factor-1 concentrations in patients with anorexia nervosa: the influence of partial realimentation. Physiol. Res. 2012;61:153–159. PubMed

Zhang R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol. 2016;6:150272. doi: 10.1098/rsob.150272. PubMed DOI PMC

Kersten S, et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 2009;29:969–974. doi: 10.1161/ATVBAHA.108.182147. PubMed DOI

Dutton S, Trayhurn P. Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br. J. Nutr. 2008;100:18–26. doi: 10.1017/S0007114507882961. PubMed DOI

Minicocci I, et al. Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism. J. Lipid Res. 2016;57:1097–1107. doi: 10.1194/jlr.P066183. PubMed DOI PMC

Tjeerdema N, et al. Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes. BMJ Open Diabetes Res. Care. 2014;2:e000034. doi: 10.1136/bmjdrc-2014-000034. PubMed DOI PMC

Abu-Farha M, et al. Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D. Lipids Health Dis. 2016;15:181. doi: 10.1186/s12944-016-0337-x. PubMed DOI PMC

Jonker JT, et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am. J. Clin. Nutr. 2013;97:255–260. doi: 10.3945/ajcn.112.043687. PubMed DOI

Xu A, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc. Natl Acad. Sci. USA. 2005;102:6086–6091. doi: 10.1073/pnas.0408452102. PubMed DOI PMC

Wang Y, et al. Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice. Mol. Med. Rep. 2016;14:3293–3300. doi: 10.3892/mmr.2016.5637. PubMed DOI

Chung HS, et al. Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study. Cardiovasc. Diabetol. 2016;15:1. doi: 10.1186/s12933-015-0324-y. PubMed DOI PMC

Zhao D, et al. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Cardiovasc. Diabetol. 2016;15:132. doi: 10.1186/s12933-016-0450-1. PubMed DOI PMC

Nidhina Haridas PA, et al. Regulation of angiopoietin-like proteins (ANGPTLs) 3 and 8 by insulin. J. Clin. Endocrinol. Metab. 2015;100:E1299–E1307. doi: 10.1210/jc.2015-1254. PubMed DOI

Tikka A, et al. Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation. Biosci. Rep. 2014;34:e00160. doi: 10.1042/BSR20140115. PubMed DOI PMC

Gusarova V, et al. ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys. J. Lipid Res. 2015;56:1308–1317. doi: 10.1194/jlr.M054890. PubMed DOI PMC

Dewey FE, et al. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N. Engl. J. Med. 2017;377:211–221. doi: 10.1056/NEJMoa1612790. PubMed DOI PMC

Cullberg KB, et al. Effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects. Obesity (Silver Spring) 2013;21:454–460. doi: 10.1002/oby.20060. PubMed DOI

Mandard S, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 2004;279:34411–34420. doi: 10.1074/jbc.M403058200. PubMed DOI

Romeo S, et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 2009;119:70–79. PubMed PMC

Nidhina Haridas PA, et al. Regulation of angiopoietin-like proteins (ANGPTLs) 3 and 8 by insulin. J. Clin. Endocrinol. Metab. 2015;100:E1299–E1307. doi: 10.1210/jc.2015-1254. PubMed DOI

Cardio- and Neurometabolic Adipobiology: Consequences and Implications for Therapy